We’ll walk through how launching on Bio works and how decentralized science can offer a faster, easier path to biotech funding and R&D.
RSVP now: luma.com/launchwithbio
@bioprotocol.bsky.social
Biotech's new financial layer. Coin your science on Bio Protocol. Fund your research now → bio.xyz/scientists
We’ll walk through how launching on Bio works and how decentralized science can offer a faster, easier path to biotech funding and R&D.
RSVP now: luma.com/launchwithbio
Struggling to raise for your science?
Join us next THURSDAY for a livestream exploring how Bio is helping researchers fund and accelerate their work with James Sinka, Bio's Chief Science Officer & Ethan Perlstein, Founder of Curetopia.
Fund your research with Bio: bio.xyz/scientists
Or refer a researcher who launches on Bio and earn 20K $BIO as a referral fee.
Researchers can now fund, develop and disseminate their science more efficiently through Bio.
➛ User-friendly tools to fund, coordinate & commercialize your research
➛ End-to-end blockchain logistics, so you can focus on science
➛ Access to a global network of investors & early adopters
For researchers, this is what becomes possible with fast access to capital, minimal overhead, a direct path from discovery to clinic, and transparent IP ownership.
If you are building in science, start here: www.bio.xyz/scientists
Bio made it possible to protect discoveries and involve patients directly.
IP stays in the hands of families through anti-shelving provisions, with 120+ rare disease groups connected via CombinedBRAIN.
The AARS2 rare disease program shows what happens when science becomes lean and transparent.
Two new drug targets discovered for under $100K in total research costs, completed within months.
Both targets are now minted as IP-NFTs, and next-generation drug screenings are underway.
• $1.8M raised in February 2025
• Ten new drug screens completed
• IP-NFTs minted and patents filed
• N-of-1 clinical studies now launching
“Very excited to have converted that 100K into several clinical candidates,” said Dr. Perlstein at DeSci Berlin.
In traditional science, years often pass between an idea and the first experiment.
With Curetopia, Ethan is proving how Bio enables faster funding, leaner operations, and parallel progress across several clinical programs.
From Harvard labs to FDA Phase 3 trials, Dr. Ethan Perlstein is proving what happens when science moves onchain.
He is using Bio to systematically attack over 10,000 rare diseases with efficiency the old system could never reach.
The new era of scientific progress 🧵
Bio Ecosystem Science Updates 🔬
From clinical studies to real-world pilots, Bio's pipeline of research projects is rapidly advancing.
Track scientific progress across decentralized biotechs in the Bio Network → www.linkedin.com/pulse/you-we...
Last week in the Biosphere:
• VitaSTEM, the 1st Aubrai IP Token, shows how humans + AI Agents can co-drive R&D
• Men’s Health BioAgent D1ckGPT launches w/ Thailand-based doctors
• Aubrai hits funding milestone
• BioXP revamp underway
Read the full weekly report ➡️ www.bio.xyz/blog-posts/b...
How Bio works in a nutshell 🧪
Send this to your normie friends.
2 weeks left to enter the Aubrai Hypothesis Challenge
Offering up to $100K in research funding for the best longevity hypotheses selected by @aubreydegrey.bsky.social's lab & VitaDAO.
→ Learn how to use Aubrai to submit a hypothesis and qualify for research funding: aubr.ai/hypothesis-c...
September was a big month in the Bio Ecosystem 🌐
> $6.9M raise anchored by MaelstromFund
> BiomeAI & edmt Ignition Sales
> Aubrai advances hypotheses to in vitro interventions
> DeSci Seoul + Singapore
> New BioAgents & IPTs on-deck
Read the full monthly report: www.bio.xyz/blog-posts/b...
📚 Read the weekly report now: www.bio.xyz/blog-posts/b...
22.09.2025 05:45 — 👍 0 🔁 0 💬 0 📌 0> Aubrai, the first BioAgent, recently crossed $275K in monthly research funding generated from market-making fees in the $AUBRAI token. Funding is directed to the lab of Dr. @aubreydegrey.bsky.social and its ongoing RMR2 Life Extension study feeding data into the agent.
+ much more!
Big week in the Biosphere ⚗️
> New Ignition Sales:
1) BiomeAI: a BioAgent for personalized microbiome health & trials
2) eDMT: an IP-Token exploring natural DMT production in the brain developed in partnership with a University of Florida lab
🧪 Submit your hypotheses: docs.google.com/forms/d/e/1F...
18.09.2025 09:25 — 👍 0 🔁 0 💬 0 📌 0Know someone who might be interested in submitting a research proposal? They could be student, medical professional or independent researcher.
Pass along this opportunity, have them reference you in the form below, and if their hypothesis is selected, you get paid 20K $BIO tokens.
► Use Aubrai on X to create and refine a longevity hypothesis
► Best hypotheses are selected by @aubreydegrey.bsky.social and qualify for up to $100K in funding
► 20K $BIO bounty for referring researchers whose hypotheses get selected
Longevity Hypothesis Challenge 💥
Are you a researcher or big-brained longevity enthusiast?
Submit hypotheses to Aubrai on X (@Aubrai_) to qualify for up to $100K in research funding 🧵
Last week in the Biosphere 🌐
> IP Tokens coming to Bio V2
> Ignition Sale next week for $BIO + BioXP holders
> Vibe science w/ Aubrai
> $100K Longevity Hypothesis Challenge
> BioXP drop & updates
> VitaDAO proposes funding for FOXO3 gene
📖 Read the full weekly update: www.bio.xyz/blog-posts/b...
Vibe Science Session 👾
Join @aubreydegrey.bsky.social and VitaDAO researchers TODAY for a live 'Vibe Science' demo of the Aubrai terminal.
See hypotheses built, agent-to-lab workflows & get updates on the RMR2 study feeding data into the agent.
RSVP now: luma.com/aubraidemo
Sept 30: DeSci Singapore luma.com/DeSciSG2025
12.09.2025 06:13 — 👍 0 🔁 0 💬 0 📌 0Sept 25: bio/acc rave Seoul luma.com/BIOxSEOUL
12.09.2025 06:13 — 👍 0 🔁 0 💬 1 📌 0Sept 23: Sideblock On The Hill luma.com/s6x3f2v2
12.09.2025 06:13 — 👍 0 🔁 0 💬 1 📌 0Sept 22: AI X Data Summit by DeSci Seoul luma.com/uu2dehmi
12.09.2025 06:13 — 👍 0 🔁 0 💬 1 📌 0A biotech renaissance is emerging in the East.
Fearless founders, regulatory agility, massive capital inflows.
This month & next, we're touring Asia with DeSci summits, a bio/acc rave & countless IRL meetings.
Here are some places we’ll be. RSVP links below. DM to meet.
Bio Weekly
From AI-powered R&D funnels to .edu airdrops - read about what's happening at the intersection of DeSci and longevity research ➡️ www.bio.xyz/blog-posts/b...